Security key
M74240108
NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)
CUSIP: M74240108
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / ORDINARY SHARES
- Total 13F shares
- 217,265
- Total 13F value
- $733,000
- Share change
- +48,413
- SEC-reported price per share
- $3.37
- Number of holders
- 7
- Value change
- +$65,709
- Number of buys
- 7
- Number of sells
- 4
Report period
Q2 2022
Institutions
7
Top holders
7
NRSN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
NeuroSense Therapeutics Ltd. SEC filings
NeuroSense Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M74240108
Recent filing periods:
Ownership snapshot
Top reported holders of NRSN - NeuroSense Therapeutics Ltd. - ORDINARY SHARES (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
0/11
Latest evidence
31 Mar 2022
13F
Highest disclosed value: $397,000
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
Ikarian Capital, LLC has the largest disclosed position value at $397K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Disclosed position value
Top 5
Ikarian Capital, LLC
$397K
JANE STREET GROUP, LLC
$173K
Empery Asset Management, LP
$96K
Hudson Bay Capital Management LP
$90K
BANK OF MONTREAL /CAN/
$65K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
—
class O/S missing
|
$397,000
100,000 shares
|
— | 31 Mar 2022 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
class O/S missing
|
$173,000
43,498 shares
|
— | 31 Mar 2022 |
| Empery Asset Management, LP |
13F
Company
|
—
class O/S missing
|
$96,000
160,000 shares
|
— | 31 Mar 2022 |
| Hudson Bay Capital Management LP |
13F
Company
|
—
class O/S missing
|
$90,000
150,000 shares
|
— | 31 Mar 2022 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
—
class O/S missing
|
$65,000
10,000 shares
|
— | 31 Mar 2022 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$48,000
12,170 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
217,265
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
7
Q2 2022 holders
7
Holder diff
0
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend